Theravance Biopharma (TBPH) Raw Materials (2013 - 2018)

Theravance Biopharma (TBPH) has 6 years of Raw Materials data on file, last reported at $10.8 million in Q3 2018.

• Raw Materials for Q3 2018 came in at $10.8 million, up 8.41% year-over-year; the trailing twelve-month figure through Sep 2018 was $10.8 million (up 8.41% YoY), and the FY2017 annual result was $11.7 million, up 93.32% from the prior year.
• Raw Materials rose to $10.8 million in Q3 2018 per TBPH's latest filing, from $10.6 million in the prior quarter.
• Over five years, Raw Materials peaked at $11.7 million in Q4 2017 and troughed at $4.0 million in Q1 2014.
• A 5-year average of $7.6 million and a median of $6.9 million in 2015 frame the typical range for Raw Materials.
• The sharpest annual moves came in 2016 and 2017: Raw Materials decreased 21.94% in 2016, then jumped 93.32% in 2017.
• A 5-year view of Raw Materials shows it stood at $6.8 million in 2014, then advanced by 0.57% to $6.9 million in 2015, then fell by 11.68% to $6.1 million in 2016, then jumped by 93.32% to $11.7 million in 2017, then dropped by 8.05% to $10.8 million in 2018.
• Business Quant data shows TBPH's Raw Materials at $10.8 million in Q3 2018, $10.6 million in Q2 2018, and $10.6 million in Q1 2018.